NB
Insider
Neal C Bradsher
DirectorNeal C Bradsher (Director) filed 3 Form 4 reports in the past 24 months (3 purchases, 0 sales), most often in STAA. Across 3 priced purchase filings, the average 21-session return was -2.4% from execution and -7.0% from disclosure (delay-adjusted; derived). The largest single filing was $6.3M of STAA (411,430 sh across 5 lots, as filed), executed Feb 12 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-2.4%
avg across 3 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-7.0%
same 3 filings, from disclosure
Filings, ttm
3
3 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.9M
shares × price, as filed
Last traded
Feb 14 2025
Filed Feb 14 2025
Volume by month
Buys $12.9M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
3 filings
Sector per market data · by filing · past 24 months
Most traded names
STAA
STAA
STAA · 2 buys · 0 sells
2 filings
LCTX
LCTX
LCTX · 1 buy · 0 sells
1 filing
Recent filings
STAAPURCHASE
STAAR SURGICAL CO
View filing →
$6.3M411,430 sh across 5 lots
Exec Feb 12 2025
Filed Feb 14 2025 · 5:30 PM ET LCTXPURCHASE Lineage Cell Therapeutics, Inc. View filing → $6.0M
7,894,737 sh × $0.76
Exec Jan 27 2025
Filed Jan 28 2025 · 5:30 PM ET STAAPURCHASE STAAR SURGICAL CO View filing → $631K
29,376 sh across 2 lots
Exec Jan 14 2025
Filed Jan 16 2025 · 5:30 PM ET